Is Kanna Legal in Spain? 2026 EU Regulatory Breakdown

Kanna (Sceletium tortuosum) is attracting growing interest across Spain and Europe — and one of the first questions anyone asks before purchasing is a simple one: is it legal?

The short answer is yes — kanna is legal in Spain and across the vast majority of Europe. It is not listed as a controlled substance in any EU-wide narcotics framework, and it does not appear on international drug control conventions. For most people in Spain and the EU, purchasing, possessing, and selling kanna as a botanical product is legally straightforward.

But the longer answer requires some nuance. Botanical products exist within a complex regulatory landscape that covers not just drug control law, but also food law, novel food regulations, medicinal product legislation, and import controls. Understanding where kanna sits within these frameworks — and where edge cases exist — is important for both buyers and sellers.

This guide provides a comprehensive, country-by-country overview of kanna's legal status across Europe, along with practical guidance on what the regulatory framework means for purchasing and selling in Spain and the EU.

The Starting Point: What Makes a Plant Legal or Illegal in Europe?

Before diving into country-specific details, it helps to understand the different legal frameworks that can affect a botanical product in Europe.

Controlled substance legislation — The most relevant framework for most buyers. EU member states maintain lists of controlled narcotics and psychotropic substances, largely based on UN conventions (the 1961 Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances). Sceletium tortuosum does not appear on either of these international conventions, which forms the basis of its legal status across most of Europe.

Novel food regulation — EU Regulation 2015/2283 governs "novel foods" — foods or food ingredients that were not widely consumed in the EU before May 1997. If a plant is classified as a novel food, it requires pre-market authorisation before being sold as a food or food supplement. This is a separate question from drug control law and is relevant specifically for products marketed for human consumption.

Medicinal product legislation — If a product is marketed with health or therapeutic claims — suggesting it treats, prevents, or cures a condition — it can be classified as a medicinal product under EU Directive 2001/83/EC, which requires full pharmaceutical authorisation. This applies regardless of whether the underlying substance is controlled.

Import and customs regulations — Plant materials crossing international borders are subject to phytosanitary controls. South African exports of Sceletium tortuosum require proper documentation from licensed producers, including export permits from Cape Nature (the conservation authority of the Western Cape).

Kanna's legal situation in Europe is primarily governed by the first framework — it is not a controlled substance. The other frameworks become relevant depending on how a product is marketed and sold, which is why responsible suppliers position kanna as a botanical specimen for research and educational purposes rather than as a food supplement or medicinal product.

Spain: Legal Status and Regulatory Framework

In Spain, Sceletium tortuosum is not listed as a controlled or prohibited substance under Spanish drug control legislation. The plant, its seeds, raw material, and extracts are not specifically prohibited, and there are no restrictions on the purchase or possession of kanna as a botanical product.

Spanish drug control law is governed primarily by the Ley Orgánica 1/1992 and subsequent legislation implementing EU and UN drug control frameworks. Kanna does not appear in any of the relevant controlled substance schedules.

Key points for buyers in Spain:

  • Purchasing kanna extract or powder as a botanical product is legal
  • Possession is not restricted under drug control law
  • No specific import prohibition exists for personal quantities

Key points for sellers in Spain:

  • Selling kanna as a botanical specimen is legal
  • Marketing it with health, therapeutic, or medicinal claims would trigger pharmaceutical legislation requiring regulatory approval — which does not currently exist for kanna
  • Positioning it as a food or dietary supplement could invoke novel food regulations
  • Responsible sellers position kanna explicitly as a raw botanical specimen for research and educational purposes

Spain is one of the most straightforward EU jurisdictions for kanna. There is no legal ambiguity around the plant itself — only around how it is marketed and what claims are made about it.

European Union: The General Framework

At the EU level, Sceletium tortuosum is not classified as a controlled drug. It does not appear on the EU's list of new psychoactive substances, nor on the international conventions that form the basis of EU drug control law.

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has not issued any control recommendations for Sceletium tortuosum or its alkaloids. This is an important indicator — substances that attract regulatory concern typically appear in EMCDDA monitoring before national controls are introduced.

Novel food status is worth addressing specifically, as it comes up frequently in discussions about kanna's EU legal status. Sceletium tortuosum does appear in the EU Novel Food Catalogue — but appearing in the catalogue does not mean it is banned. It means its novel food status is listed as "on hold" pending further information, which effectively means it cannot currently be sold as a food or food supplement in the EU without authorisation. This is not a prohibition on the plant itself — it is a restriction on its use as a food ingredient. Botanical specimens sold for research and educational purposes are not subject to novel food regulation.

Country-by-Country Guide

Germany

Kanna is not a controlled substance in Germany. It does not appear on the Betäubungsmittelgesetz (BtMG) — Germany's narcotics act — or its annexes. Purchasing and possessing kanna as a botanical product is legal. Germany has an active nootropics and botanical wellness community and kanna is available from several suppliers shipping to German customers.

France

Sceletium tortuosum is not listed as a controlled substance in France. French drug control legislation does not specifically address kanna, and it is not subject to any specific prohibition. As with other EU countries, marketing claims are the primary regulatory consideration — the plant itself is not restricted.

Netherlands

The Netherlands has one of the most developed botanical wellness markets in Europe and kanna has been available there for many years. It is not a controlled substance under Dutch law (Opiumwet). The Netherlands is one of the more established European markets for kanna products and has multiple domestic suppliers.

Italy

Italy warrants specific mention as it is occasionally cited as a more restrictive jurisdiction. Some Italian regulatory texts reference mesembrine — the primary alkaloid in kanna — in controlled substance lists, though the plant Sceletium tortuosum itself is not broadly listed as controlled. The situation in Italy is less clear-cut than in most other EU member states and buyers or sellers in Italy are advised to verify the current status of specific alkaloids under Italian law before purchasing.

Sweden

Sweden has historically taken a stricter approach to psychoactive botanicals than most EU member states. While Sceletium tortuosum is not explicitly listed as a controlled substance under Swedish law, Sweden's broad application of its Narcotics Drugs Act (Narkotikastrafflagen) to substances with psychoactive properties means the legal situation warrants more careful attention. Buyers in Sweden should verify current status before purchasing.

Denmark

Denmark operates a similar framework to Sweden and has been proactive in scheduling novel psychoactive substances. Sceletium tortuosum is not currently scheduled in Denmark, but as with Sweden, the regulatory environment for psychoactive botanicals is more active than in southern European countries and buyers should stay informed of any developments.

United Kingdom

Post-Brexit, the UK operates its own regulatory framework independent of the EU. Kanna is not listed as a controlled substance under the UK Misuse of Drugs Act 1971 or its schedules. The UK has one of the most developed kanna markets in Europe, with multiple established suppliers operating legally. For EU-based buyers, UK suppliers require international shipping which adds cost and delivery time compared to EU-based alternatives.

Netherlands, Belgium, Luxembourg

The Benelux countries share broadly similar regulatory frameworks regarding kanna. None list Sceletium tortuosum as a controlled substance and the plant is available legally in all three countries as a botanical product.

Portugal

Portugal's famously progressive drug policy focuses on decriminalisation of personal use rather than legalisation, and applies primarily to commonly used substances. Kanna is not specifically addressed in Portuguese drug law and is not a controlled substance. It is available as a botanical product.

Poland, Romania, Latvia, Lithuania

These EU member states have taken more proactive approaches to novel psychoactive substance legislation. While Sceletium tortuosum is not currently specifically scheduled in most of these countries, the regulatory environment for botanical products with psychoactive properties is more active. Buyers in these countries are advised to verify current local regulations before purchasing.

Austria, Switzerland

Kanna is not a controlled substance in Austria (EU member) or Switzerland (non-EU). Both countries have active supplement and botanical wellness markets. As with all jurisdictions, marketing claims rather than the plant itself are the primary regulatory consideration.

Practical Guidance for Buyers in Spain and the EU

For individual buyers across Spain and most of the EU, the practical situation is straightforward: purchasing kanna extract as a botanical product from a responsible supplier is legal.

What to look for in a supplier:

A responsible EU-based kanna supplier will position their products explicitly as botanical specimens for research and educational purposes — not as food supplements or medicines. They will have full documentation of their supply chain, including export permits from South African authorities (Cape Nature export permits are the relevant documentation for South African Sceletium tortuosum), and batch-level Certificates of Analysis (COA) verifying alkaloid content, pesticide screening, heavy metal testing, and microbial analysis tested to European Pharmacopoeia standards.

Sourcing from a supplier who can provide this documentation is not just a quality consideration — it also provides confidence about the legitimacy of the supply chain and the proper export and import of the product.

Import for personal use:

Plant materials imported from outside the EU are subject to phytosanitary controls at the border. Reputable suppliers handle this documentation as part of their supply chain and ship within EU customs frameworks. Buying from an EU-based supplier eliminates most of the import complexity that would arise from ordering directly from a South African producer as an individual.

Practical Guidance for Sellers in Spain and the EU

For businesses selling kanna in Spain and the EU, the regulatory framework requires attention to how products are positioned and marketed.

The legal sale of kanna in the EU is straightforwardly possible when products are positioned as raw botanical specimens for research and educational purposes. Problems arise when sellers make health claims, position products as food supplements or medicines, or fail to maintain proper supply chain documentation.

Specifically, sellers should:

  • Never make health, therapeutic, or medicinal claims about kanna products
  • Not position products as food supplements or dietary supplements
  • Maintain full supply chain documentation including supplier COAs and export permits
  • Ensure product labelling clearly states the research and educational purpose
  • Stay informed of any regulatory developments regarding novel food classification or national scheduling decisions in target markets

Summary: Is Kanna Legal in Europe?

For most people in Spain and across the EU — yes, kanna is legal. Sceletium tortuosum is not a controlled substance in EU-wide drug control frameworks or international conventions, and the vast majority of EU member states do not specifically schedule it.

The nuances that exist relate primarily to how products are marketed (health claims trigger pharmaceutical regulation), how they are sold (novel food regulation applies if sold as food supplements), and a small number of member states with more active novel psychoactive substance legislation where buyers should verify current status.

For buyers in Spain specifically — one of the most straightforward EU jurisdictions for kanna — purchasing a quality, COA-verified kanna extract from a responsible supplier is a legal and increasingly accessible option.

Sceletic Co. is based in Barcelona and sources its Sceletium tortuosum extracts directly from licensed South African producers, with full Cape Nature export documentation and batch-level COAs tested to European Pharmacopoeia standards. MT55 and MZ0 extracts are available with delivery across Spain in 2-3 days and EU-wide shipping.

Disclaimer: This article is for informational and educational purposes only and does not constitute legal advice. Laws and regulations change and the information provided here reflects general understanding at the time of writing — February 2026. Always verify the current legal status in your specific country before purchasing or selling any botanical product. Kanna products sold by Sceletic Co. are raw botanical specimens for research and educational purposes only and are not intended for human consumption. Consult a qualified legal professional for specific legal advice regarding your jurisdiction.

Back to blog